Controlled Substance Diversion Prevention in ASCs

The Scope of the Diversion Problem

Controlled substance diversion, the theft or misuse of medications intended for patients, is a significant concern in all healthcare settings, including ambulatory surgery centers. The DEA and state boards of pharmacy take diversion seriously, and ASCs have a legal and ethical obligation to implement prevention and detection measures.

Diversion can involve any staff member who has access to controlled substances: nurses, anesthesia providers, physicians, technicians, and even non-clinical staff if physical security is inadequate. The consequences include patient harm (under-dosing), legal liability, loss of DEA registration, and accreditation jeopardy.

Warning Signs of Diversion

Documentation Red Flags

• Frequent discrepancies in controlled substance counts
• Consistently higher waste amounts compared to peers
• Late or retrospective documentation entries
• Patterns of charting maximum doses for all patients
• Discrepancies between documented administration and patient-reported pain levels

Behavioral Red Flags

• Volunteering to handle controlled substances for other staff
• Arriving early or staying late without clear reason
• Frequent bathroom breaks or trips to the medication storage area
• Defensive behavior when controlled substance procedures are discussed
• Signs of substance impairment: mood changes, drowsiness, dilated or constricted pupils, coordination issues
• Declining job performance or attendance issues

Systemic Red Flags

• Specific medications consistently showing shortages
• Discrepancies that resolve when a particular individual is absent
• Waste occurring without a witness or with the same witness repeatedly
• Security camera blind spots in medication storage areas

Prevention Strategies

Physical Security

• Store all controlled substances in locked, tamper-evident storage
• Limit access to authorized personnel only
• Use individual access codes or biometric access rather than shared keys
• Install security cameras in medication storage areas and document retention schedules
• Secure waste containers to prevent retrieval of discarded medications

Procedural Controls

• Dual verification: Require two licensed individuals for waste, with both present at the time of waste (not retrospective witnessing)
• Perpetual inventory: Maintain real-time running counts of all controlled substances
• 72-hour counts: Comply with TSBP 291.76 verification requirements
• Count at shift change: When possible, verify counts at the beginning and end of each shift
• Standard administration documentation: Require specific documentation of dose, route, time, and patient response
• Limit quantities: Stock only the quantities needed for a typical day's cases

Monitoring and Analytics

• Review controlled substance usage patterns by individual, by medication, and by time period
• Compare usage patterns across staff members performing similar roles
• Monitor waste rates and flag outliers
• Track discrepancy frequency and investigate trends
• Review patient satisfaction scores for pain management alongside CS usage data

Culture and Education

• Establish a non-punitive reporting culture for concerns about diversion
• Educate all staff on diversion warning signs and reporting procedures
• Include diversion prevention in new employee orientation
• Conduct annual refresher training
• Make clear that diversion reporting is mandatory, not optional

Responding to Suspected Diversion

When diversion is suspected, follow a structured response:

Immediate Steps

1. Do not confront the individual directly: This can result in evidence destruction or flight
2. Secure the evidence: Preserve all relevant documentation, logs, and recordings
3. Notify the pharmacist-in-charge and facility administrator
4. Document your observations: Record specific facts, not opinions or conclusions
5. Restrict access if necessary: Consider temporarily reassigning the individual away from controlled substance handling

Investigation

1. Conduct a thorough review of the individual's controlled substance transactions
2. Analyze trends over time, not just recent events
3. Review security camera footage if available
4. Interview relevant staff as needed
5. Engage legal counsel if the investigation supports diversion

Reporting Requirements

If diversion is confirmed or strongly suspected:

• DEA: Report theft or significant loss using DEA Form 106
• TSBP: Report to the Texas State Board of Pharmacy if a licensed pharmacist or pharmacy technician is involved
• State nursing board: Report if a nurse is involved
• Local law enforcement: Consider reporting to law enforcement, especially if patient harm occurred
• Employer obligations: Follow facility policies for employment action

Failure to report known diversion can expose the facility and its administrators to regulatory and legal liability.

The Role of Technology in Diversion Prevention

Digital controlled substance management tools provide capabilities that paper systems cannot:

• Automated trend analysis across staff, medications, and time periods
• Real-time alerts for anomalies that would take weeks to detect manually
• Immutable audit trails that support investigations
• Per-user analytics that compare individual patterns to facility norms
• Integration with electronic health records for cross-referencing administration records with patient charts

These tools do not replace professional judgment and a strong compliance culture, but they provide the data foundation that makes effective oversight possible.